Description

1H-[1,2,4]Oxadiazolo[4,3-A]Quinoxalin-1-One,4,5-Dihydro-(9Ci) is a specialized heterocyclic organic compound belonging to the fused oxadiazolo-quinoxaline class, serving as a critical synthetic intermediate and research chemical. Its unique fused-ring structure makes it a valuable building block for developing novel pharmacologically active molecules and advanced materials. This compound is primarily utilized by research institutions and pharmaceutical companies engaged in medicinal chemistry, particularly for the synthesis of compounds targeting neurological and inflammatory pathways.

Application

• Pharmaceutical Intermediate: Key precursor in the synthesis of potential drug candidates, especially those acting on central nervous system (CNS) targets.
• Medicinal Chemistry Research: Used as a core scaffold for designing and optimizing new chemical entities with potential biological activity.
• Biochemical Tool Compound: Employed in biochemical assays and as a reference standard for studying specific enzyme interactions or receptor binding.
• Agrochemical Development: Intermediate in the research and development of new pesticides or herbicides with novel modes of action.
• Material Science Research: Investigated for the development of organic electronic materials or specialty polymers due to its conjugated system.
• Academic & Contract Research: Supplied to universities and CROs (Contract Research Organizations) for fundamental organic synthesis and discovery chemistry projects.

Basic Information

Product Name	1H-[1,2,4]Oxadiazolo[4,3-A]Quinoxalin-1-One,4,5-Dihydro-(9Ci)
CAS No.	36002-67-2
Molecular Formula	C9H6N4O2
Molecular Weight	202.17 g/mol
Synonyms	4,5-Dihydro-1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one; 1H-[1,2,4]Oxadiazolo[4,3-a]quinoxalin-1-one, 4,5-dihydro-; ODQ (common research abbreviation for this class); 36002-67-2; Quinoxaline-1,2,4-oxadiazole derivative; Fused oxadiazoloquinoxalinone
EINECS	Contact for details

Quality Control

Our 1H-[1,2,4]Oxadiazolo[4,3-A]Quinoxalin-1-One,4,5-Dihydro-(9Ci) is produced under strict quality management systems to ensure batch-to-batch consistency and high purity for research applications. All products undergo rigorous analytical testing, including HPLC for purity and identity confirmation via spectroscopic methods (NMR, IR, MS). A comprehensive Certificate of Analysis (COA) detailing purity, assay, and impurity profiles is provided with each shipment to support your research and regulatory documentation needs.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated area at a controlled room temperature (typically 15-25°C). This compound is light-sensitive (store away from light). Keep away from incompatible materials. For long-term storage, consider storing under an inert atmosphere to ensure optimal stability.

Specification

Item	Specification
Appearance	Off-white to light yellow crystalline powder
Identification (IR)	Conforms to structure
Identification (HPLC)	Retention time matches reference standard
Purity (HPLC)	≥ 97.0% (Area %)
Assay	≥ 95.0% (by HPLC normalization)
Water Content (KF)	≤ 0.5%
Residue on Ignition	≤ 0.1%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.